Parkinson's Experts to Headline Free Sunflower Revolution Symposium & Expo
The event will take place from 10 a.m. to 3:15 p.m. Saturday, Sept. 6, at the Hyatt Regency Cincinnati. The Symposium & Expo is a project of the Neuroscience Institute at the University of Cincinnati (UC) and
Online registration is available at www.sunflowerrev.org. For more information, call (513) 569-5354 or contact TNI-events@healthall.com.
Presenters at the event will include members of the Davis Phinney Foundations national Scientific Advisory Board. Topics include an overview of treatments, developments in clinical and laboratory research, the impact of lifestyle on the biology of Parkinsons disease, occupational and physical therapy rehabilitation and strategies for successful caregiving.
The three-day Sunflower Revolution weekend also includes a gala fundraiser (Sept. 5) and bike rides of 20, 40 and 100 kilometers (Sept. 7).
The
The Neuroscience Institute is dedicated to patient care, research, education, and the development of new treatments for stroke, brain and spinal tumors, epilepsy, traumatic brain and spinal injury, multiple sclerosis, Alzheimers disease, Parkinsons disease, disorders of the senses (swallowing, voice, hearing, pain, taste, and smell) and psychiatric conditions (bipolar disorder, schizophrenia and depression).
Tags
Related Stories
Certain weather patterns can trigger migraines
June 8, 2026
Certain weather patterns really do trigger migraine headaches — and the incidence is more common in the Midwest. As WGN 9 in Chicago recently reported, researchers at the University of Cincinnati College of Medicine have identified two specific weather patterns associated with an increased risk of headaches.
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.